Stay updated on ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial

Sign up to get notified when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now references Revision: v3.5.4, replacing Revision: v3.5.3, indicating a minor revision update to the page's release notes.
    Difference
    0.0%
    Check dated 2026-05-15T02:29:25.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s “Revision” (site/system version) label was updated from v3.5.0 to v3.5.3, reflecting a backend or platform update rather than a change to the displayed study results.
    Difference
    0.0%
    Check dated 2026-04-23T18:45:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Key results data and descriptions were removed from the Study Results page, including participant counts by timepoint and arm, and several primary/secondary outcomes (LDL-C, PCSK9, triglycerides, ApoB) along with adverse events.
    Difference
    0.9%
    Check dated 2026-04-01T02:53:26.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0; this appears to be a versioning change rather than substantive content updates.
    Difference
    0.0%
    Check dated 2026-03-24T20:44:12.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-16T18:25:01.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is added and updated results sections include Absolute Change in PCSK9 Levels From Baseline for ORION-3 at Days 30, 360, 720 and 1440 with corresponding participants. LDL-C and related outcome data points have been updated or clarified, and arm descriptions/timeframes are explained.
    Difference
    0.2%
    Check dated 2026-02-11T02:40:06.000Z thumbnail image

Stay in the know with updates to ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ORION-3 Extension Trial: Inclisiran in Cardiovascular Disease Clinical Trial page.